5-Amino-1MQ — The NNMT Inhibitor That Targets the Enzyme Keeping Your Fat Cells in Storage Mode

5-Amino-1MQ

There is an enzyme operating in your fat cells right now that most people have never heard of. It is called NNMT — nicotinamide N-methyltransferase — and in people with metabolic dysfunction, excess body fat or age-related metabolic decline, it tends to be significantly overexpressed. When NNMT is overactive it suppresses the cellular energy currency that fat cells need to burn stored fat — essentially keeping them in a mode that favours fat storage over fat oxidation regardless of what else you do.

5-Amino-1MQ was developed specifically to inhibit this enzyme. The results in preclinical research — fat loss without changes to food intake, improved glucose tolerance, reduced adipocyte size — have generated significant interest in the research community. And the mechanism, which operates at a more fundamental level than appetite suppression or hormonal signalling, makes it genuinely distinct from every other compound in this section of the library.

Before going further, one important clarification that most sites in this space fail to make clearly. 5-Amino-1MQ is a small molecule compound — not a peptide. With a molecular weight of approximately 159 Da, it is far smaller than even the smallest peptides, which typically start around 500 to 1,000 Da. It contains no amino acid chain and is not a peptide by any chemical definition. It is sold by peptide vendors and discussed in peptide communities — which is why it appears in this library — but the distinction matters for understanding its mechanism and how it works. Astra Labs

What Is 5-Amino-1MQ?

5-Amino-1MQ — 5-Amino-1-Methylquinolinium — is a small molecule NNMT inhibitor first described in academic literature in the context of obesity research, with early animal studies published in journals including Nature Chemical Biology showing meaningful reductions in adiposity without changes to food intake.

NNMT is an enzyme overexpressed in adipose tissue and certain metabolic disorders. It catalyses the methylation of nicotinamide, consuming S-adenosylmethionine — SAM — and reducing intracellular NAD+ availability. By inhibiting NNMT, 5-Amino-1MQ increases NAD+ levels, enhances cellular energy metabolism, and shifts fat cell activity from lipid storage toward lipid oxidation. Astra Labs

That finding — fat loss without appetite suppression or changes to food intake — is what has made 5-Amino-1MQ a topic of significant interest among those whose metabolic goals centre on body composition and cellular energy rather than simply reducing how much they eat.

How Does 5-Amino-1MQ Work?

The mechanism of 5-Amino-1MQ operates at what can genuinely be described as a foundational level — the regulation of cellular energy currency itself.

5-Amino-1MQ competitively inhibits NNMT, reducing its activity and allowing NAD+ precursors and SAM to be redirected toward their intended metabolic functions. The downstream effect in animal studies has been increased fat oxidation, reduced adipocyte size, improved insulin sensitivity and meaningful reductions in body fat mass. Tide Labs

NAD+ — nicotinamide adenine dinucleotide — is one of the most important molecules in cellular metabolism. It is essential for mitochondrial energy production, the activation of sirtuins — the longevity-associated proteins — and the efficient operation of the metabolic machinery that determines whether cells burn or store fat. When NNMT is overactive it depletes both NAD+ and SAM — two molecules that fat cells absolutely require to oxidise stored fat effectively. The result is a cellular environment that is biased toward fat storage regardless of caloric intake or exercise.

In laboratory studies using 3T3-L1 adipocytes, 5-Amino-1MQ significantly reduced intracellular levels of 1-methylnicotinamide, confirming successful NNMT inhibition. Simultaneously NAD+ levels increased by 1.2 to 1.6 fold compared to untreated cells. Fast Life Hacks

Beyond fat metabolism specifically, NNMT inhibition appears to increase expression of GLUT4 transporters — which move glucose from the bloodstream into cells — improving blood sugar regulation and reducing excess glucose available to be converted into fat. Tide Labs

A separate but equally interesting research avenue has emerged around muscle ageing — NNMT inhibition elevated muscle stem cell proliferation and fusion, supporting nearly 2-fold greater cross-sectional area and increased peak muscle torque by approximately 70% compared with controls in aged skeletal muscle, suggesting improved regenerative capacity. statista

What Does the Research Show?

Honesty about the evidence position of 5-Amino-1MQ is particularly important — because the mechanism is genuinely compelling but the human evidence base is at an early stage.

In diet-induced obese mice, 5-Amino-1MQ reduced body fat mass without changing food intake, improved glucose tolerance, and decreased adipocyte size, consistent with enhanced lipid oxidation. statista

A 2025 study in Biomolecules found that NNMT inhibitor treatment reduces body weight, white adipose tissue mass, total cholesterol and adipocyte size in obese mice — suggesting cardiovascular benefit beyond simple weight loss. Lab Grade Peptides

These are genuinely meaningful results — but they are animal studies. No published human clinical trials of 5-Amino-1MQ exist as of April 2026. All reported effects come from mouse studies. Preclinical findings in rodents do not reliably predict human outcomes, particularly in metabolic research where multiple prior targets failed to replicate in human trials. statista

Human clinical trial activity is emerging but not yet mature — published human efficacy data are not yet established. MY PEPTIDES

This is the honest picture. The mechanism is scientifically sound and well-understood. The preclinical results are consistently positive and meaningful. The human evidence is not yet there in the way it is for the GLP-1 compounds or even for MOTS-c which is now entering Phase 2a human trials. For those engaging with 5-Amino-1MQ right now, they are doing so on the strength of compelling animal data, a coherent and well-researched mechanism, and accumulated research community experience — which is worth taking seriously, while also understanding clearly what it is and what it is not.

Who Is 5-Amino-1MQ Most Relevant For?

Given its mechanism and evidence position, 5-Amino-1MQ is most relevant for a specific group — and being clear about this makes it a more genuinely useful compound rather than a less interesting one.

It is most compelling for people whose primary interest is metabolic optimisation at a cellular level — improving how fat cells function rather than simply reducing food intake or amplifying hormonal signals. Someone who is already relatively lean, already training and eating well, and whose remaining body composition challenge relates more to metabolic efficiency than caloric balance is the person most likely to find 5-Amino-1MQ genuinely interesting.

It is also particularly relevant in the context of longevity and healthy ageing — given its NAD+ preservation properties and the relationship between NAD+ depletion and age-related metabolic decline. In a longevity-focused protocol combining 5-Amino-1MQ with other NAD+ supporting compounds and mitochondrial health peptides like MOTS-c creates a genuinely coherent and biologically well-reasoned approach.

Its oral bioavailability is a practical advantage worth noting — unlike most compounds in this library, 5-Amino-1MQ does not require subcutaneous injection, which makes it more accessible for many people and simpler to incorporate into a daily protocol.

Dosage and Protocol

The commonly used 50 to 150mg daily range is based on translated preclinical research data and several years of community experience. Start at 50mg once daily for the first one to two weeks. If well tolerated, increase to 100mg — this is the dose most users settle on. Astra Labs

Standard Research Protocol:

Starting dose: 50mg once daily — weeks 1 to 2
Standard dose: 100mg once daily — from week 3 onwards
Maximum explored: 150mg daily — for those who have tolerated 100mg well and are seeking additional effect
Administration: Oral — capsule or dissolved powder. This is one of the few compounds in this library that does not require injection
Timing: Morning administration is most commonly used — with or without food, as oral bioavailability is not significantly affected by food intake
Cycle length: 8 to 12 weeks, followed by a break of 4 weeks before repeating

The oral administration route makes this one of the most accessible compounds in the library from a practical standpoint — no reconstitution, no injection, no rotation of sites. A straightforward daily capsule taken in the morning as part of a broader supplement routine.

A Note on Reconstitution

Unlike every other compound covered in the Weight Loss section of this library, 5-Amino-1MQ does not require reconstitution. It is orally bioavailable and typically supplied in capsule form or as a powder that can be taken directly. There is no bacteriostatic water, no insulin syringe and no mixing ratio to calculate — which is one of its practical advantages over injectable research peptides.

If you have sourced it in powder form rather than capsules, it can be weighed and dissolved in water for oral administration — standard laboratory scales accurate to 1mg are sufficient for measuring the 50 to 100mg doses used in research protocols.

Supporting Supplements

The supplements that most coherently complement 5-Amino-1MQ are those that work alongside its NAD+ preservation and NNMT inhibition mechanism.

NMN or NR — NAD+ precursors — are the most directly relevant pairing. 5-Amino-1MQ preserves NAD+ by preventing its depletion through NNMT activity. NMN or NR directly replenish NAD+ precursors. The two approaches work through complementary mechanisms — preservation and replenishment — creating a more complete NAD+ support strategy than either alone.

Resveratrol activates sirtuins — the NAD+ dependent longevity proteins — complementing the increased NAD+ availability that 5-Amino-1MQ supports. It is one of the most commonly recommended pairings in the research community.

CoQ10 supports mitochondrial energy production — directly relevant given that the improved cellular energy metabolism 5-Amino-1MQ drives requires well-functioning mitochondria to convert that potential into actual energy output.

Magnesium supports the enzymatic processes involved in NAD+ metabolism and the hundreds of other cellular reactions that depend on it.

Vitamin D maintains the broader hormonal and metabolic environment — particularly relevant given its relationship with insulin sensitivity and metabolic function.

Alpha Lipoic Acid — another AMPK activator and powerful mitochondrial antioxidant — complements 5-Amino-1MQ’s metabolic optimisation effects through a related but distinct pathway.

Foods That Complement 5-Amino-1MQ

The nutritional approach that best supports 5-Amino-1MQ’s mechanism centres on maintaining the metabolic environment where NNMT inhibition and NAD+ preservation produce the most meaningful results.

Foods naturally rich in NAD+ precursors deserve particular attention alongside this compound — chicken, turkey, tuna, salmon, mushrooms, green peas and whole grains all contain meaningful amounts of niacin and related compounds that support NAD+ biosynthesis.

Lean protein at every meal maintains the muscle mass and glucose uptake capacity that 5-Amino-1MQ is improving — protecting the lean tissue that the compound’s GLUT4 upregulation is making more metabolically active.

Low glycaemic whole foods — oats, legumes, sweet potato, berries and leafy vegetables — support the improved blood sugar regulation that 5-Amino-1MQ facilitates, creating a stable metabolic environment throughout the day.

Cruciferous vegetables — broccoli, cauliflower, Brussels sprouts — support the metabolic pathways that NNMT inhibition is working to optimise and contribute meaningfully to the anti-inflammatory environment in which cellular fat oxidation occurs most effectively.

Refined carbohydrates, ultra-processed foods and alcohol all suppress NAD+ availability and metabolic flexibility — working directly against the mechanism through which 5-Amino-1MQ operates.

Lifestyle Considerations

Resistance training is the most valuable lifestyle addition alongside 5-Amino-1MQ — particularly given the emerging research on NNMT inhibition and muscle regeneration. The combination of improved cellular energy metabolism, better glucose uptake and the muscle stem cell benefits observed in preclinical research makes resistance training the obvious complement to what 5-Amino-1MQ is doing at a cellular level.

Intermittent fasting creates a natural metabolic environment that complements 5-Amino-1MQ’s mechanism — the fasted state increases reliance on fat oxidation for energy, which aligns directly with what NNMT inhibition is working to facilitate. Morning administration during an intermittent fasting window is a particularly coherent approach.

Sleep quality is directly relevant — NAD+ is consumed during DNA repair and cellular maintenance processes that occur primarily during sleep. Supporting NAD+ availability through the day makes adequate, high quality sleep even more important.

Stress management — chronic cortisol elevation impairs insulin sensitivity and metabolic flexibility, working against the improvements 5-Amino-1MQ is driving at a cellular level.

Compound Pairing

5-Amino-1MQ pairs naturally with compounds that complement its cellular metabolic optimisation approach.

MOTS-c is the most scientifically coherent pairing in this library — MOTS-c activating AMPK and improving metabolic flexibility through mitochondrial signalling while 5-Amino-1MQ preserves NAD+ and shifts fat cell activity toward oxidation through NNMT inhibition. The two mechanisms are genuinely distinct and address cellular metabolism from different but complementary angles simultaneously.

AOD-9604 is sometimes used alongside 5-Amino-1MQ for body composition — AOD-9604 targeting fat metabolism through beta-3 adrenergic pathways while 5-Amino-1MQ works through NNMT inhibition, creating two distinct and potentially additive approaches to fat oxidation.

Epithalon in a longevity-focused protocol — addressing cellular ageing through telomere biology and pineal function while 5-Amino-1MQ addresses the NAD+ and metabolic dimensions of ageing. Together with MOTS-c this three-way stack represents one of the most biologically coherent longevity-focused protocols available.

CJC-1295 with Ipamorelin in a pre-sleep protocol adds the growth hormone dimension — particularly relevant for active individuals using 5-Amino-1MQ as part of a broader body composition and longevity protocol.

Realistic Expectations

5-Amino-1MQ is a compound that rewards a sophisticated understanding of what it is and what it is not. It is not a dramatic weight loss intervention — the GLP-1 compounds do that better and with more evidence behind them. It is a cellular metabolic optimisation tool that works at a level most compounds in this space cannot reach.

For the right person — already lean, already active, interested in the cellular mechanisms of fat metabolism and metabolic health rather than simply a lower number on the scale — 5-Amino-1MQ offers something genuinely interesting. Its oral convenience, its NAD+ preservation properties and its distinct mechanism make it a compelling addition to a well-structured metabolic health or longevity protocol.

The honest caveat remains — the human evidence base is still being established. Human clinical trial activity is emerging but completed efficacy trials are not yet established. Those engaging with it now are doing so as the science develops — which is the position many of the most interesting compounds in this library occupy. MY PEPTIDES

Used consistently, alongside the nutritional and lifestyle foundations this site covers in depth and ideally paired with complementary compounds like MOTS-c and appropriate NAD+ support — 5-Amino-1MQ represents one of the more intellectually interesting approaches to body composition and metabolic health available in the research community right now.

For research grade 5-Amino-1MQ with independent third party Certificate of Analysis documentation, Complete Peptides supplies verified compounds at [completepeptides.co.uk]

For an overview of the full weight loss and metabolic health landscape visit the [Weight Loss Overview]. For the complete longevity focused protocol combining 5-Amino-1MQ with complementary compounds visit the [Longevity Stack Protocol]. For definitions of any terms used on this page visit the [Glossary].